Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial-Reference-Cited by-同舟云学术

Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial

Published:2017 Issue:5 Volume:2 Page:e000261
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Van Cutsem Eric,Falcone Alfredo,Garcia-Carbonero Rocio,Komatsu Yoshito,Pastorino Alessandro,Peeters Marc,Shimada Yasuhiro,Yamazaki Kentaro,Yoshino Takayuki,Zaniboni Alberto,Amellal Nadia,Kanehisa Akira,Winkler Robert,Makris Lukas,Mayer RobertJ,Ohtsu Atsushi,Tabernero Josep

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. The cancer patient and quality of life;Bottomley;Oncologist,2002

4. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience;Bottomley;J Clin Oncol,2007

5. The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials;Funaioli;J Chemother,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial;BMC Cancer;2024-07-23

2. Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes – a review;Frontiers in Oncology;2024-07-12

3. Combination of Modest Dosage of Bevacizumab with TAS-102 Provided the Comparable Efficacy in Treating Refractory Metastatic Colorectal Cancer;2024-06-20

4. Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis;International Journal of Colorectal Disease;2023-01-11

5. Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis;Therapeutic Advances in Medical Oncology;2023-01